Morgan Stanley Downgrades Alpine Immune Sciences (ALPN) to Equalweight
Tweet Send to a Friend
(Updated - April 11, 2024 3:58 AM EDT)
Morgan Stanley analyst Michael Ulz downgraded Alpine Immune Sciences (NASDAQ: ALPN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Michael Ulz downgraded Alpine Immune Sciences (NASDAQ: ALPN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
